Benchmarking Complications Associated with Esophagectomy
作者:Donald E. Low, Madhan Kumar Kuppusamy, Derek Alderson, Ivan Cecconello, Andrew C. Chang, Gail Elizabeth Darling, Andrew Davies, Xavier Benoît D’Journo, Suzanne Sarah Gisbertz, S M Griffin, Richard Henry Hardwick, Arnulf H. Hoelscher, Wayne Lewis Hofstetter, Blair A. Jobe, Yuko Kitagawa, Simon Ying-Kit Law, C. Mariette, Nick Maynard, Christopher R. Morse, Philippe Robert Nafteux, Manuel Pera, Conjeevaram S. Pramesh, Sonia Puig, John Vincent Reynolds, Wolfgang Schroeder, Bernard Mark Smithers, Bas P. L. Wijnhoven · 发表于:Annals of Surgery · 年份:2017 · DOI:10.1097/sla.0000000000002611 · 被引用次数:903 · 研究领域:Esophageal Cancer Research and Treatment、Esophageal and GI Pathology、Cardiac, Anesthesia and Surgical Outcomes
OBJECTIVE: Utilizing a standardized dataset with specific definitions to prospectively collect international data to provide a benchmark for complications and outcomes associated with esophagectomy. SUMMARY OF BACKGROUND DATA: Outcome reporting in oncologic surgery has suffered from the lack of a standardized system for reporting operative results particularly complications. This is particularly the case for esophagectomy affecting the accuracy and relevance of international outcome assessments, clinical trial results, and quality improvement projects. METHODS: The Esophageal Complications Consensus Group (ECCG) involving 24 high-volume esophageal surgical centers in 14 countries developed a standardized platform for recording complications and quality measures associated with esophagectomy. Using a secure online database (ESODATA.org), ECCG centers prospectively recorded data on all resections according to the ECCG platform from these centers over a 2-year period. RESULTS: Between January 2015 and December 2016, 2704 resections were entered into the database. All demographic and follow-up data fields were 100% complete. The majority of operations were for cancer (95.6%) and typically located in the distal esophagus (56.2%). Some 1192 patients received neoadjuvant chemoradiation (46.1%) and 763 neoadjuvant chemotherapy (29.5%). Surgical approach involved open procedures in 52.1% and minimally invasive operations in 47.9%. Chest anastomoses were done most commonly (60.7%) and ...